
    
      About 125 subjects were planned to be included and assigned to the experimental group and the
      control group according to 4:1.At the same time, a liver biopsy group was set up in each part
      of the population to receive liver biopsy during the screening period and 48 weeks after
      completion of drug administration, which was used to detect HBV DNA, cccDNA, HBsAg, and
      evaluate the degree of liver inflammation and fibrosis.
    
  